Alfred Bach

Title: Alfred Bach: Inventor in Neuroprotective Research

Introduction

Alfred Bach is an inventor associated with Edingen-Neckarhausen, Germany. His work includes a patent concerning methods and biological tools for identifying potential protective treatments for neurodegenerative and ischemic disorders.

Latest Patents

Bach is credited with 1 patent: “Screening Method for Identifying Protective Substances for Treating Neurodegenerative and/or Ischemic Disorders.” The invention describes a screening method for identifying substances that influence haemoglobin formation in neuronal, myocardial, or skeletal-muscle cells. It also covers recombinant constructs, host cells, and transgenic animals used to implement the method. Related applications described in the patent include differential diagnosis of neurodegenerative and ischemic diseases, potential therapeutic uses of haemoglobin and related proteins or nucleic acids, and gene-therapy constructs.

Career Highlights

Bach is associated with Sygnis Bioscience GmbH & Co. KG. The patent’s focus on screening, diagnosis, and potential treatment reflects an effort to explore haemoglobin-related approaches to neurological and ischemic conditions.

Collaborations

The supplied information identifies Wolfgang Kuschinsky and Armin Schneider as Bach’s coworkers. Their names are associated with the collaborative research context surrounding the invention.

Conclusion

Alfred Bach’s recorded patent connects biological screening and haemoglobin research with potential diagnostic and therapeutic approaches to neurodegenerative and ischemic disorders.